Persistent inflammation during anti-tuberculosis treatment with diabetes comorbidity

  1. Nathella Pavan Kumar
  2. Kiyoshi F Fukutani
  3. Basavaradhya S Shruthi
  4. Thabata Alves
  5. Paulo S Silveira-Mattos
  6. Michael S Rocha
  7. Kim West
  8. Mohan Natarajan
  9. Vijay Viswanathan
  10. Subash Babu
  11. Bruno B Andrade
  12. Hardy Kornfeld  Is a corresponding author
  1. National Institutes of Health, India
  2. Fundação José Silveira, Brazil
  3. Prof M Viswanathan Diabetes Research Center, India
  4. University of Massachusetts Medical School, United States
  5. National Institute for Research in Tuberculosis, India

Peer review process

This article was accepted for publication via eLife's original publishing model. eLife publishes the authors' accepted manuscript as a PDF only version before the full Version of Record is ready for publication. Peer reviews are published along with the Version of Record.

History

  1. Version of Record published
  2. Accepted Manuscript published
  3. Accepted
  4. Received

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Nathella Pavan Kumar
  2. Kiyoshi F Fukutani
  3. Basavaradhya S Shruthi
  4. Thabata Alves
  5. Paulo S Silveira-Mattos
  6. Michael S Rocha
  7. Kim West
  8. Mohan Natarajan
  9. Vijay Viswanathan
  10. Subash Babu
  11. Bruno B Andrade
  12. Hardy Kornfeld
(2019)
Persistent inflammation during anti-tuberculosis treatment with diabetes comorbidity
eLife 8:e46477.
https://doi.org/10.7554/eLife.46477

Share this article

https://doi.org/10.7554/eLife.46477